Johnson & Johnson (JNJ)
Exchange: New York Stock Exchange
Currency: USD
Price: 0.00 ()
Summary
| 52 Week range | 200d Moving Avg. | Beta |
| 0.00 – 0.00 | 0.00 | 0.00 |
| Dividend | Dividend Yield | Ex-Dividend date |
| 0.00 | 0.00% | 0000-00-00 |
| P/E Ratio | Latest EPS | DGR 3 years |
| 22.39 | 5.61 | 5.78% |
Overvalued
Low
N.A.
High
Slow
Dividend Growth
Fast
Profile
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
| Sector: | Industry: | |
| Health Technology | Pharmaceuticals: Major | |
 |
 |
Total ESG Score
36 – 72 percentile
Environment
4 – 7 percentile
Social
25 – 7 percentile
Governance
15 – 7 percentile
Controversy level
4
MSCI ESG-Rating
BBB
see MSCI ESG rating explained
Peers
– Cardinal Health Inc. (CAH)
– AbbVie Inc. (ABBV)
– Abbott Laboratories (ABT)
– Becton Dickinson (BDX)
– Medtronic plc (MDT)
– West Pharmaceutical Services, Inc (WST)
Dividend Safety Metrics
| Latest EPS | 5.61 | |
| Annual Payout | 0.00 | |
| Payout Ratio | 0.00% | |
| Dividend growth | 57 Years | |
| Dividend Score | 73 | |
| Dividend Coverage Ratio | 0.00 | |
| Altman-Z score | 4.22 | Safe Zone |
Estimated Future Total Return Metrics
| Total return last 5Y | 8.80% | |
| Dividend growth 5Y | 5.87% | |
| Current dividend yield | 0.00% | |
| Average dividend yield last 5Y | 2.53% | |
| Estimated EPS growth next 5Y | 7.50% | |
| Extra return due to over/under valuation | -100.00% | |
| Estimated future return 5Y (CAGR) | -90.00% |
Johnson & Johnson (JNJ) Valuation
Johnson & Johnson current dividend yield of 0.00% is -100% below its 5-year average. The 5-year average dividend yield is 2.53% (see red-line in chart). This indicates the stock looks overvalued today.
Johnson & Johnson (JNJ) Performance
The chart below displays the total price return(%) of Johnson & Johnson for different periods:
Johnson & Johnson (JNJ) Total Return
The chart below displays the (CAGR) total return (%) including all dividends paid of Johnson & Johnson for different periods:
Dividend Scorecard
| Dividend Yield (TTM) | Annual Payout | Payout Ratio | Dividend growth |
| 0.00 | 0.00 | 0.00% | 57 Years |
Dividend Growth Summary
| 3 Year Growth Rate (CAGR) | 5.78% |
| 5 Year Growth Rate (CAGR) | 5.87% |
| 10 Year Growth Rate (CAGR) | 6.42% |
Dividend Growth Rates History
| Year | Payout Amount | Annual Payout Growth (YoY) |
|---|---|---|
| 2022 | 1.060 | -74.7% |
| 2021 | 4.190 | 5.3% |
| 2020 | 3.980 | 6.1% |
| 2019 | 3.750 | 5.9% |
| 2018 | 3.540 | 6.6% |
| 2017 | 3.320 | 5.4% |
| 2016 | 3.150 | 6.8% |
| 2015 | 2.950 | 6.9% |
| 2014 | 2.760 | 6.6% |
| 2013 | 2.590 | 7.9% |
| 2012 | 2.400 | 6.7% |
| 2011 | 2.250 | 6.6% |
| 2010 | 2.110 | 9.3% |
| 2009 | 1.930 | 7.5% |
| 2008 | 1.795 | 10.8% |
Johnson & Johnson (JNJ) Dividend Payment History